Immunome Inc. Current Ratio in % from Q2 2021 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Immunome Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q3 2025.
Immunome Inc. Current Ratio for the quarter ending September 30, 2025 was 790 %, a 5.78% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Immunome Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	790	+43.2	+5.78%	Sep 30, 2025
Q2 2025	723	+1.46	+0.2%	Jun 30, 2025
Q1 2025	652	+75.2	+13%	Mar 31, 2025
Q4 2024	646	+311	+92.9%	Dec 31, 2024
Q3 2024	747	+502	+205%	Sep 30, 2024
Q2 2024	721	+512	+245%	Jun 30, 2024
Q1 2024	577	+294	+104%	Mar 31, 2024
Q4 2023	335	-76.1	-18.5%	Dec 31, 2023
Q3 2023	245	-234	-48.9%	Sep 30, 2023
Q2 2023	209	-354	-62.8%	Jun 30, 2023
Q1 2023	283	-456	-61.8%	Mar 31, 2023
Q4 2022	411	-456	-52.6%	Dec 31, 2022
Q3 2022	479	-622	-56.5%	Sep 30, 2022
Q2 2022	563	-370	-39.6%	Jun 30, 2022
Q1 2022	739			Mar 31, 2022
Q4 2021	867			Dec 31, 2021
Q3 2021	1.1K			Sep 30, 2021
Q2 2021	933			Jun 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.